
Drugs IPOs Depend o...


| CYTC | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 60.20 |
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 0.00 | 0.00 | |
| Net Income | 0.00 | 0.00 | |
| EPS | 0.00 | 0.00 |
| EBITDA | -34.00 |
| REVENUE | 0.00 |
| Qtr (09/07) | Qtr (12/07) | FY (12/07) | FY (12/08) | |
|---|---|---|---|---|
| Average Estimate | $0.34 | $0.37 | $1.34 | $1.62 |
| Number of Analysts | 2 | 2 | 2 | 2 |
| High Estimate | $0.00 | $0.00 | $1.00 | $2.00 |
| Low Estimate | $0.00 | $0.00 | $1.33 | $1.61 |
| Prior Year | $0.31 | $0.33 | $1.15 | $1.34 |
| Growth Rate (Year over Year) | 9.68% | 10.61% | 16.09% | 20.97% |